Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

NANot yet recruitingINTERVENTIONAL
Enrollment

686

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2028

Study Completion Date

January 1, 2029

Conditions
Ventilator-Associated Pneumonia (VAP)
Interventions
PROCEDURE

control group

immediate empiric Antibiotic Therapy (started within 1 hour after randomization) with antibiotic(s) chosen by the bedside physician based on time of ventilator-associated pneumoniaoccurrence, risk of antimicrobial resistance, local ecology, and local protocol. If the respiratory samples are negative, Antibiotic Therapy will be stopped. If ventilator-associated pneumonia is confirmed by positive samples, Antibiotic Therapy active against the recovered bacterial specie(s) will be given for a total of 7 days.

PROCEDURE

Conservative strategy

No Antibiotic Therapy until receipt of the respiratory sample culture and/or polymerase chain reaction results. If these results are negative, no Antibiotic Therapy is given. If they are positive (confirmed ventilator-associated pneumonia), Antibiotic Therapy is started as appropriate for the bacterial specie(s) detected by culture and/or polymerase chain reaction, without considering gram-stain results and without waiting for antimicrobial susceptibility testing results, and continued for a total of 7 days of Antibiotic Therapy active against the identified bacterial specie(s).

Trial Locations (40)

13637

CH d'Arles, Arles

16000

CH Angoulème, Angoulème

21033

CHU Dijon, Dijon

33076

CHU de Bordeaux, Bordeaux

35033

CHU Rennes, Rennes

35403

CH de Saint-Malo, St-Malo

37044

CHRU De Tours, Tours

40000

CH de Mont de Marsan, Mont-de-Marsan

40107

CH Dax, Dax

43000

CH Emile Roux, Le Puy-en-Velay

44000

CHU Nantes, Nantes

44600

CH de Saint-Nazaire, Saint-Nazaire

45100

CHR d'Orléans, Orléans

49000

CHU Angers, Angers

49325

CH Cholet, Cholet

50102

CH Public du Cotentin, Cherbourg

56017

CH Bretagne Atlantique, Vannes

56100

GHB Sud- Hôpital de Lorient, Lorient

59037

CHRU Lille, Lille

59300

CH de Valenciennes, Valenciennes

63003

CHU Clermont-Ferrand, Clermont-Ferrand

64000

CH de Pau, Pau

67091

CHRU de Strasbourg - Nouvel Hôpital Civil, Strasbourg

67098

CHRU de Strasbourg -Hôpital de Hautepierre, Strasbourg

69437

CHU de Lyon - Hôpital Edouard Herriot, Lyon

72000

CH Le Mans, Le Mans

75014

APHP - Hôpital Cochin, Paris

75020

APHP - Hôpital Tenon, Paris

77000

CH de Melun, Melun

78157

CH Versailles, Le Chesnay

84000

CH Avignon, Avignon

85025

CHD Vendée, La Roche-sur-Yon

90000

Hôpital Nord Franche Comté, Belfort

92150

Hôpital Foch, Suresnes

92380

APHP - Hôpital Raymond Poincaré, Garches

95100

CH Argenteuil, Argenteuil

97159

CHU La Guadeloupe, Pointe-à-Pitre

06414

CH Simone Veil, Cannes

06100

CHU Nice -Hôpital Pasteur, Nice

06200

CHU Nice - Hôpital de l'Archet, Nice

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT06743529 - Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia | Biotech Hunter | Biotech Hunter